RUNX1 (RUNX family transcription factor 1)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
861 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
RUNX family transcription factor 1 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
RUNX1 |
SynonymsGene synonyms aliases
|
AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1, PEBP2aB, PEBP2alpha |
ChromosomeChromosome number
|
21 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
21q22.12 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs74315450 |
C>T |
Pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs121912498 |
T>C |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
rs121912499 |
G>A,C,T |
Pathogenic, likely-pathogenic, likely-benign |
Non coding transcript variant, coding sequence variant, stop gained, synonymous variant, genic downstream transcript variant |
rs121912500 |
G>T |
Pathogenic, likely-benign |
Missense variant, non coding transcript variant, coding sequence variant |
rs150042294 |
C>T |
Likely-benign, conflicting-interpretations-of-pathogenicity |
Intron variant, missense variant, non coding transcript variant, coding sequence variant |
rs561166961 |
C>A |
Likely-pathogenic, uncertain-significance |
Missense variant, coding sequence variant, non coding transcript variant |
rs761390141 |
C>A,G,T |
Conflicting-interpretations-of-pathogenicity |
3 prime UTR variant, genic downstream transcript variant |
rs769628054 |
G>A |
Conflicting-interpretations-of-pathogenicity |
Synonymous variant, downstream transcript variant, genic downstream transcript variant, coding sequence variant |
rs1057519748 |
G>A |
Pathogenic, likely-pathogenic |
Coding sequence variant, stop gained, non coding transcript variant |
rs1060502579 |
C>G,T |
Pathogenic, likely-pathogenic |
Splice donor variant |
rs1555884790 |
->CG |
Pathogenic, likely-pathogenic |
Downstream transcript variant, frameshift variant, genic downstream transcript variant, coding sequence variant |
rs1555889984 |
C>A |
Pathogenic |
Intron variant, non coding transcript variant, stop gained, coding sequence variant |
rs1555899735 |
A>T |
Uncertain-significance, likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1555899813 |
->CC |
Pathogenic |
Frameshift variant, non coding transcript variant, coding sequence variant |
rs1569001972 |
->AGCCGCCCACCATGGAGAACTGGTAGGAGCCGGCCGAGGCGCCGTAGTACAGGTGGTAGGAGGG |
Likely-pathogenic |
Downstream transcript variant, frameshift variant, genic downstream transcript variant, coding sequence variant |
rs1569002077 |
->CCGA |
Likely-pathogenic |
Downstream transcript variant, frameshift variant, genic downstream transcript variant, coding sequence variant |
rs1569002159 |
->GAGC |
Likely-pathogenic |
Downstream transcript variant, frameshift variant, genic downstream transcript variant, coding sequence variant |
rs1569002296 |
G>T |
Likely-pathogenic |
Downstream transcript variant, stop gained, genic downstream transcript variant, coding sequence variant |
rs1569002881 |
G>A |
Likely-pathogenic |
Stop gained, non coding transcript variant, genic downstream transcript variant, coding sequence variant |
rs1569008655 |
G>A |
Pathogenic, likely-pathogenic |
Stop gained, non coding transcript variant, genic downstream transcript variant, coding sequence variant |
rs1569009004 |
G>- |
Likely-pathogenic |
Frameshift variant, non coding transcript variant, genic downstream transcript variant, coding sequence variant |
rs1569037127 |
G>- |
Likely-pathogenic |
Intron variant, frameshift variant, non coding transcript variant, coding sequence variant |
rs1569061762 |
C>T |
Pathogenic, likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1569061768 |
G>A |
Pathogenic, likely-pathogenic |
Non coding transcript variant, stop gained, coding sequence variant |
rs1569061786 |
T>A,G |
Uncertain-significance, likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1569061831 |
G>C |
Pathogenic |
Non coding transcript variant, stop gained, coding sequence variant |
rs1569084032 |
G>- |
Likely-pathogenic |
Frameshift variant, non coding transcript variant, coding sequence variant |
rs1569084082 |
C>G |
Pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1569084106 |
C>T |
Likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1569084116 |
T>G |
Uncertain-significance, likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1569084170 |
G>- |
Pathogenic |
Frameshift variant, non coding transcript variant, coding sequence variant |
rs1569084388 |
CC>- |
Likely-pathogenic |
Frameshift variant, non coding transcript variant, coding sequence variant |
rs1569084451 |
CGCCGCTCCTCAGCTTGCCGGCCAGGGCAGCGCCGGCGTCCGGGGCGCCCAGC>- |
Likely-pathogenic |
Frameshift variant, non coding transcript variant, coding sequence variant |
rs1569084530 |
->GGCGTCCGGGGCGCCCAGCGGCAACGCC |
Pathogenic |
Frameshift variant, non coding transcript variant, coding sequence variant |
rs1569084646 |
G>- |
Likely-pathogenic |
Frameshift variant, non coding transcript variant, coding sequence variant |
rs1601333051 |
C>- |
Likely-pathogenic |
Downstream transcript variant, frameshift variant, genic downstream transcript variant, coding sequence variant |
rs1601415426 |
G>A |
Likely-pathogenic |
Intron variant, non coding transcript variant, stop gained, coding sequence variant |
rs1601470652 |
A>T |
Likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1601528621 |
G>T |
Likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1601528701 |
GAGCAGAGGAA>CAGCGGAAGGAG |
Pathogenic |
Frameshift variant, non coding transcript variant, coding sequence variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT000107 |
hsa-miR-27a-3p |
HITS-CLIP |
23313552 |
MIRT003741 |
hsa-miR-17-5p |
Luciferase reporter assay, Reporter assay, qRT-PCR, Western blot |
17589498 |
MIRT003742 |
hsa-miR-20a-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
17589498 |
MIRT003743 |
hsa-miR-106a-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
17589498 |
MIRT038069 |
hsa-miR-423-5p |
CLASH |
23622248 |
MIRT053591 |
hsa-miR-675-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
24388988 |
MIRT053591 |
hsa-miR-675-5p |
qRT-PCR, Western blot |
26931432 |
MIRT203374 |
hsa-miR-8485 |
HITS-CLIP |
23824327 |
MIRT203374 |
hsa-miR-8485 |
HITS-CLIP |
23313552 |
MIRT203374 |
hsa-miR-8485 |
HITS-CLIP |
27418678 |
MIRT438218 |
hsa-miR-221-3p |
qRT-PCR, Western blot |
24329418 |
MIRT534539 |
hsa-miR-7111-3p |
PAR-CLIP |
22012620 |
MIRT534540 |
hsa-miR-4792 |
PAR-CLIP |
22012620 |
MIRT534541 |
hsa-miR-6721-5p |
PAR-CLIP |
22012620 |
MIRT534542 |
hsa-miR-6860 |
PAR-CLIP |
22012620 |
MIRT534543 |
hsa-miR-612 |
PAR-CLIP |
22012620 |
MIRT534544 |
hsa-miR-5189-5p |
PAR-CLIP |
22012620 |
MIRT534545 |
hsa-miR-3187-5p |
PAR-CLIP |
22012620 |
MIRT534546 |
hsa-miR-1285-3p |
PAR-CLIP |
22012620 |
MIRT534547 |
hsa-miR-939-3p |
PAR-CLIP |
22012620 |
MIRT534548 |
hsa-miR-6769b-3p |
PAR-CLIP |
22012620 |
MIRT534549 |
hsa-miR-4723-3p |
PAR-CLIP |
22012620 |
MIRT534550 |
hsa-miR-3183 |
PAR-CLIP |
22012620 |
MIRT534551 |
hsa-miR-6791-5p |
PAR-CLIP |
22012620 |
MIRT534552 |
hsa-miR-4292 |
PAR-CLIP |
22012620 |
MIRT534553 |
hsa-miR-4308 |
PAR-CLIP |
22012620 |
MIRT534554 |
hsa-miR-4762-5p |
PAR-CLIP |
22012620 |
MIRT534555 |
hsa-miR-605-5p |
PAR-CLIP |
22012620 |
MIRT534556 |
hsa-miR-551b-5p |
PAR-CLIP |
22012620 |
MIRT534556 |
hsa-miR-551b-5p |
HITS-CLIP |
23313552 |
MIRT569539 |
hsa-miR-4417 |
PAR-CLIP |
20371350 |
MIRT569540 |
hsa-miR-4467 |
PAR-CLIP |
20371350 |
MIRT569541 |
hsa-miR-6853-5p |
PAR-CLIP |
20371350 |
MIRT569542 |
hsa-miR-8072 |
PAR-CLIP |
20371350 |
MIRT569543 |
hsa-miR-4530 |
PAR-CLIP |
20371350 |
MIRT569544 |
hsa-miR-3960 |
PAR-CLIP |
20371350 |
MIRT569545 |
hsa-miR-922 |
PAR-CLIP |
20371350 |
MIRT612533 |
hsa-miR-4789-3p |
HITS-CLIP |
23824327 |
MIRT612533 |
hsa-miR-4789-3p |
HITS-CLIP |
23313552 |
MIRT612533 |
hsa-miR-4789-3p |
HITS-CLIP |
27418678 |
MIRT622381 |
hsa-miR-335-3p |
HITS-CLIP |
23824327 |
MIRT622381 |
hsa-miR-335-3p |
HITS-CLIP |
27418678 |
MIRT622382 |
hsa-miR-5096 |
HITS-CLIP |
23824327 |
MIRT622382 |
hsa-miR-5096 |
HITS-CLIP |
27418678 |
MIRT622383 |
hsa-miR-377-3p |
HITS-CLIP |
23824327 |
MIRT622383 |
hsa-miR-377-3p |
HITS-CLIP |
27418678 |
MIRT699881 |
hsa-miR-6885-3p |
HITS-CLIP |
23313552 |
MIRT699882 |
hsa-miR-4446-5p |
HITS-CLIP |
23313552 |
MIRT699883 |
hsa-miR-7152-5p |
HITS-CLIP |
23313552 |
MIRT699884 |
hsa-miR-5006-3p |
HITS-CLIP |
23313552 |
MIRT699885 |
hsa-miR-4755-5p |
HITS-CLIP |
23313552 |
MIRT699886 |
hsa-miR-3180-5p |
HITS-CLIP |
23313552 |
MIRT699887 |
hsa-miR-4639-5p |
HITS-CLIP |
23313552 |
MIRT699888 |
hsa-miR-4497 |
HITS-CLIP |
23313552 |
MIRT699889 |
hsa-miR-642a-5p |
HITS-CLIP |
23313552 |
MIRT699890 |
hsa-miR-513a-5p |
HITS-CLIP |
23313552 |
MIRT699891 |
hsa-miR-3160-5p |
HITS-CLIP |
23313552 |
MIRT699892 |
hsa-miR-1266-3p |
HITS-CLIP |
23313552 |
MIRT699893 |
hsa-miR-4667-3p |
HITS-CLIP |
23313552 |
MIRT699894 |
hsa-miR-1470 |
HITS-CLIP |
23313552 |
MIRT699895 |
hsa-miR-7157-5p |
HITS-CLIP |
23313552 |
MIRT699896 |
hsa-miR-4310 |
HITS-CLIP |
23313552 |
MIRT699897 |
hsa-miR-141-5p |
HITS-CLIP |
23313552 |
MIRT699898 |
hsa-miR-2115-3p |
HITS-CLIP |
23313552 |
MIRT699899 |
hsa-miR-1179 |
HITS-CLIP |
23313552 |
MIRT699900 |
hsa-miR-27b-3p |
HITS-CLIP |
23313552 |
MIRT699900 |
hsa-miR-27b-3p |
Luciferase reporter assay |
26870610 |
MIRT699901 |
hsa-miR-128-3p |
HITS-CLIP |
23313552 |
MIRT699902 |
hsa-miR-216a-3p |
HITS-CLIP |
23313552 |
MIRT699903 |
hsa-miR-3681-3p |
HITS-CLIP |
23313552 |
MIRT731126 |
hsa-miR-18a-5p |
Luciferase reporter assay, qRT-PCR, Western blot, |
25452107 |
MIRT732121 |
hsa-miR-215-5p |
Immunohistochemistry, Luciferase reporter assay, qRT-PCR, Western blot |
26716895 |
MIRT733692 |
hsa-miR-9-5p |
Luciferase reporter assay |
26091714 |
MIRT734125 |
hsa-miR-101-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
26628987 |
MIRT734389 |
hsa-miR-144-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
26030000 |
MIRT734590 |
hsa-miR-181a-5p |
Luciferase reporter assay |
26580398 |
MIRT734686 |
hsa-miR-378a-3p |
Luciferase reporter assay, qRT-PCR, Western blot, Microarray |
26749280 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
ISS |
|
GO:0000785 |
Component |
Chromatin |
ISA |
|
GO:0000976 |
Function |
Transcription regulatory region sequence-specific DNA binding |
IDA |
21873977 |
GO:0000977 |
Function |
RNA polymerase II transcription regulatory region sequence-specific DNA binding |
IDA |
9199349 |
GO:0000977 |
Function |
RNA polymerase II transcription regulatory region sequence-specific DNA binding |
IMP |
9199349 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IDA |
17377532 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IBA |
21873635 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISA |
|
GO:0001228 |
Function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IDA |
9199349 |
GO:0001228 |
Function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IMP |
9199349 |
GO:0001503 |
Process |
Ossification |
IBA |
21873635 |
GO:0001959 |
Process |
Regulation of cytokine-mediated signaling pathway |
TAS |
|
GO:0002062 |
Process |
Chondrocyte differentiation |
IBA |
21873635 |
GO:0005515 |
Function |
Protein binding |
IPI |
2845103, 10207087, 11965546, 14970218, 16917507, 17377532, 17431401, 18280240, 19497860, 21179004, 21873977, 22253733, 25241761, 25283809, 25678665, 28533407, 29391048 |
GO:0005524 |
Function |
ATP binding |
IEA |
|
GO:0005634 |
Component |
Nucleus |
IDA |
7862156 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0006357 |
Process |
Regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0010629 |
Process |
Negative regulation of gene expression |
TAS |
|
GO:0010755 |
Process |
Regulation of plasminogen activation |
ISS |
|
GO:0016513 |
Component |
Core-binding factor complex |
TAS |
18258917 |
GO:0030097 |
Process |
Hemopoiesis |
IBA |
21873635 |
GO:0030097 |
Process |
Hemopoiesis |
IDA |
21873977 |
GO:0030111 |
Process |
Regulation of Wnt signaling pathway |
TAS |
|
GO:0030182 |
Process |
Neuron differentiation |
IBA |
21873635 |
GO:0030854 |
Process |
Positive regulation of granulocyte differentiation |
IMP |
9199349 |
GO:0032743 |
Process |
Positive regulation of interleukin-2 production |
IMP |
17377532 |
GO:0032967 |
Process |
Positive regulation of collagen biosynthetic process |
ISS |
|
GO:0033146 |
Process |
Regulation of intracellular estrogen receptor signaling pathway |
TAS |
|
GO:0043231 |
Component |
Intracellular membrane-bounded organelle |
IDA |
|
GO:0043371 |
Process |
Negative regulation of CD4-positive, alpha-beta T cell differentiation |
ISS |
|
GO:0043378 |
Process |
Positive regulation of CD8-positive, alpha-beta T cell differentiation |
ISS |
|
GO:0045589 |
Process |
Regulation of regulatory T cell differentiation |
TAS |
|
GO:0045595 |
Process |
Regulation of cell differentiation |
IBA |
21873635 |
GO:0045616 |
Process |
Regulation of keratinocyte differentiation |
TAS |
|
GO:0045637 |
Process |
Regulation of myeloid cell differentiation |
TAS |
|
GO:0045652 |
Process |
Regulation of megakaryocyte differentiation |
TAS |
|
GO:0045766 |
Process |
Positive regulation of angiogenesis |
ISS |
|
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IDA |
10207087, 14970218 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IDA |
9199349, 10207087, 14970218, 21873977 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IMP |
9199349, 20972335 |
GO:0048935 |
Process |
Peripheral nervous system neuron development |
TAS |
20096094 |
GO:0050855 |
Process |
Regulation of B cell receptor signaling pathway |
TAS |
|
GO:0060043 |
Process |
Regulation of cardiac muscle cell proliferation |
ISS |
|
GO:0061026 |
Process |
Cardiac muscle tissue regeneration |
ISS |
|
GO:0071425 |
Process |
Hematopoietic stem cell proliferation |
TAS |
21873977 |
GO:1902036 |
Process |
Regulation of hematopoietic stem cell differentiation |
TAS |
|
GO:1903055 |
Process |
Positive regulation of extracellular matrix organization |
ISS |
|
GO:1905203 |
Process |
Regulation of connective tissue replacement |
ISS |
|
GO:2000810 |
Process |
Regulation of bicellular tight junction assembly |
TAS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q01196 |
Protein name |
Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) |
Protein function |
Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'-TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. The heterodimers bind to the core site of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters (Probable). Essential for the development of normal hematopoiesis (PubMed:17431401). Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the BLK promoter (PubMed:10207087, PubMed:14970218). Inhibits KAT6B-dependent transcriptional activation (By similarity). Involved in lineage commitment of immature T cell precursors. CBF complexes repress ZBTB7B transcription factor during cytotoxic (CD8+) T cell development. They bind to RUNX-binding sequence within the ZBTB7B locus acting as transcriptional silencer and allowing for cytotoxic T cell differentiation. CBF complexes binding to the transcriptional silencer is essential for recruitment of nuclear protein complexes that catalyze epigenetic modifications to establish epigenetic ZBTB7B silencing (By similarity). Controls the anergy and suppressive function of regulatory T-cells (Treg) by associating with FOXP3. Activates the expression of IL2 and IFNG and down-regulates the expression of TNFRSF18, IL2RA and CTLA4, in conventional T-cells (PubMed:17377532). Positively regulates the expression of RORC in T-helper 17 cells (By similarity). ; Isoform AML-1G shows higher binding activities for target genes and binds TCR-beta-E2 and RAG-1 target site with threefold higher affinity than other isoforms. It is less effective in the context of neutrophil terminal differentiation. ; Isoform AML-1L interferes with the transactivation activity of RUNX1. |
PDB |
1CMO
,
1CO1
,
1E50
,
1H9D
,
1LJM
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00853 |
Runt |
51 → 180 |
Runt domain |
Domain |
PF08504 |
RunxI |
362 → 453 |
Runx inhibition domain |
Family |
|
Sequence |
|
Sequence length |
453 |
Interactions |
View interactions |
|
|